Cost effectiveness of lung volume reduction surgery

Chest Surgery Clinics of North America

Volumn 13, Issue 4, 2003, Pages 727-738

  Ramsey, Scott D ^a,b,c  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUDGET; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; ECONOMIC EVALUATION; EMPHYSEMA; EXERCISE TOLERANCE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH STATUS; HUMAN; LUNG RESECTION; PHYSICAL CAPACITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REIMBURSEMENT; RESOURCE MANAGEMENT; REVIEW; SURGICAL APPROACH;

EID: 0344825950     PISSN: 10523359     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-3359(03)00097-8     Document Type: Review

References (36)

1. Flaherty KR, Kazerooni EA, Curtis JL, et al. Short-term and long-term outcomes after bilateral lung volume reduction surgery: prediction by quantitative CT. Chest 2001;119:1337-46.
2. Geddes D, Davies M, Koyama H, et al. Effect of lung-volume-reduction surgery in patients with severe emphysema. N Engl J Med 2000;343:239-45.
3. Sciurba FC, Rogers RM, Keenan RJ, et al. Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med 1996;334:1095-9.
4. Gelb AF, McKenna Jr RJ, Brenner M, Schein MJ, Zamel N, Fischel R. Lung function 4 years after lung volume reduction surgery for emphysema. Chest 1999;116:1608-15.
5. Pompeo E, Marino M, Nofroni I, Matteucci G, Mineo TC. Reduction pneumoplasty versus respiratory rehabilitation in severe emphysema: a randomized study. Pulmonary Emphysema Research Group. Ann Thorac Surg 2000;70:948-53; discussion 954.
6. Lung-Volume Reduction Surgery for End-Stage Chronic Obstructive Pulmonary Disease. Rockville, Maryland: United States Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1996. Publication No. 96-0062.
7. Gentry C. Second opinion: why Medicare covers a new lung surgery for just a few patients. Wall Street Journal June 29, 1998;A1.
8. Kaplan RM, Atkins CJ, Timms R. Validity of a Quality of Well-Being Scale as an outcome measure in chronic obstructive pulmonary disease. J Chronic Dis 1984;37:85-95.
9. Kaplan RM, Anderson JP, Patterson TL, et al. Validity of the Quality of Well-Being Scale for persons with human immunodeficiency virus infection. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med 1995;57:138-47.
10. Kaplan RM, Hartwell SL, Wilson DK, Wallace JP. Effects of diet and exercise interventions on control and quality of life in non-insulin-dependent diabetes mellitus. J Gen Intern Med 1987;2: 220-8.
11. Ganiats TG, Palinkas LA, Kaplan RM. Comparison of Quality of Well-Being Scale and Functional Status Index in patients with atrial fibrillation. Med Care 1992;30:958-64.
12. Kaplan RM. Quality of life assessment for cost/utility studies in cancer. Cancer Treat Rev 1993; 19(Suppl A):85-96.
13. Kaplan RM. Decisions about prostate cancer screening in managed care. Curr Opin Oncol 1997; 9:480-6.
14. Trulock E, Cooper JD. Reduction pneumoplasty for COPD [abstract]. Chest 1994;106:52S.
15. Huizenga HF, Ramsey SD, Albert RK. Estimated growth of lung volume reduction surgery among Medicare enrollees: 1994 to 1996. Chest 1998;114:1583-7.
16. Snider GL. Health-care technology assessment of surgical procedures: the case of reduction pneumoplasty for emphysema. Am J Respir Crit Care Med 1996;153:1208-13.
17. Make BJ, Fein AM. Is volume reduction surgery appropriate in the treatment of emphysema? No. Am J Respir Crit Care Med 1996;153:1205-7.
18. Utz JP, Hubmayr RD, Deschamps C. Lung volume reduction surgery for emphysema: out on a limb without a NETT. Mayo Clin Proc 1998;73:552-66.
19. Gold MR, Siegal JE, Russel LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
20. Kaplan RM, Anderson JP. The General Health Policy Model: an integrated approach. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd edition. Philadelphia: Lippincott-Raven Publishers; 1996.
21. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995;122:823-32.
22. Chaudhary MA, Stearns SC. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. Stat Med 1996;15:1447-58.
23. Briggs AH, O'Brien BJ, Blackhouse G. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annu Rev Public Health 2002;23: 377-401.
24. NETT Research Group. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med 2003;348:2092-102.
25. Drazen JM. Surgery for emphysema-not for everyone. N Engl J Med 2001;345:1126-7.
26. Fein AM. Lung volume reduction surgery: answering the crucial questions. Chest 1998;113: 277S-82S.
27. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995;8:1398-420.
28. Wagner JL, Alberts SR, Sloan JA, et al. Incremental costs of enrolling cancer patients in clinical trials: a population-based study. J Natl Cancer Inst 1999;91:847-53.
29. Pliskin JS, Stason WB, Weinstein MC, et al. Coronary artery bypass graft surgery: clinical decision making and cost-effectiveness analysis. Med Decis Making 1981;1:10-28.
30. Weinstein MC, Stason WB. Cost-effectiveness of coronary artery bypass surgery, Circulation 1982;66:11156-66.
31. Harvard Center for Risk Analysis. The CEA registry: standardizing the methods and practices of cost-effectiveness analysis. Available at: http://www.hsph.harvard.edu/cearegistry/. Accessed February 13, 2002.
32. Ramsey SD, Patrick DL, Albert RK, Larson EB, Wood DE, Raghu G. The cost-effectiveness of lung transplantation. A pilot study. University of Washington Medical Center Lung Transplant Study Group. Chest 1995;108:1594-601.
33. Al MJ, Koopmanschap MA, van Enckevort PJ, et al. Cost-effectiveness of lung transplantation in The Netherlands: a scenario analysis. Chest 1998;113:124-30.
34. van Hout B, Bonsel G, Habbema D, van der Maas P, de Charro F. Heart transplantation in the Netherlands: costs, effects and scenarios. J Health Econ 1993;12:73-93.
35. Harvard Center for Risk Analysis. The CEA registry: standardizing the methods and practices of cost-effectiveness analysis. Available at: http://www.hsph.harvard.edu/cearegistry/. Accessed February 13, 2002.
36. Owens DK, Sanders GD, Harris RA, et al. Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med 1997;126: 1-12.